AGENDA
| 7:00 am |
7:30 am |
Registration/Breakfast with Exhibitors |
| 7:30 am |
7:45 am |
Welcome & Introduction
Charles L. Brown, III, MD and C. Michael Valentine, MD |
| White Varietals: Lighter Content, Crispy Start |
| 7:45 am |
8:15 am |
CAC and Next Generation CTA: The New Era of Discovery
Szilard Voros, MD |
| 8:15 am |
8:30 am |
Discussion |
| 8:30 am |
9:00 am |
Direct Thrombin Inhibitors Anti-Platelet Therapy: Current Practice and Future Directions
E. Magnus Ohman, MD |
| 9:00 am |
9:15 am |
Discussion |
| 9:15 am |
9:45 am |
DES vs BMS--What Does the Data Tell Us About Long Term Safety and Outcomes?
Ralph G. Brindis, MD |
| 9:45 am |
10:00 am |
Discussion |
| 10:15 am |
10:45 am |
Arterial Puncture Management: Current State-of-the-Art and Future Options
Charles L. Brown, III, MD |
| 10:45 am |
11:00 am |
Discussion |
| 11:00 am |
11:30 am |
Pertinent Case Review and Discussion
Charles L. Brown, III, MD and C. Michael Valentine, MD |
| 6:00pm |
|
Napa Valley Reserve Tasting |
| 7:00 am |
7:30 am |
Continental Breakfast |
| Red Varietals: Heavier Content, with More of a Bite |
| 7:30 am |
8:00 am |
LMD and Multivessel CAD: To Stent or Not to Stent?
Richard A. Schatz, MD |
| 8:00 am |
8:15 am |
Discussion |
| 8:15 am |
8:45 am |
New Approaches to CTO: Have We Learned Anything from the East?
Robert S. Schwartz, MD |
| 8:45 am |
9:00 am |
Discussion |
| 9:00 am |
9:30 am |
Percutaneous and Hybrid Valve Management: State-of-the-Art and Future Options
Peter J. Fitzgerald, MD, PhD |
| 9:30 am |
9:45 am |
Discussion |
| 10:00 am |
10:30 am |
LV Recovery Management: The Interventionalist's Role
Steven J. Yakubov, MD |
| 10:30 am |
10:45 am |
Discussion |
| 10:45 am |
11:45 am |
Blending of Interventional Medicine and Business: Survival Hints for The New Era of Healthcare Delivery
Charles L. Brown, III, MD and C. Michael Valentine, MD |
| 11:45 am |
12:00 pm |
Discussion |
This activity is sponsored by Global Education Group.
Logistics and planning provided by Moceri Management.